Revenue ($USD) : $596,440,857
Revenue (foreign currencies) : JP¥83,800,000,000
R&D spend : not available
Employees : not available
Fiscal year end : 12/31/2023
CEO : Toshihiko Kai, president and CEO; Masaru Yamamura, GM, medical division

www.nikkiso.com/products/medical

Nikkiso says it holds more than half of the market for dialysis machines in Japan and has a significant global presence. The company has diversified into blood purification devices, equipment for surgery, perioperative, and emergency care, and offers artificial pancreas technology for clinical use. –CN